Trial Profile
Safety and Efficacy of Simeprevir, Sofosbuvir and Ribavirin Combination Therapy in Liver Transplant Recipients with Severe Recurrent HCV
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 08 Dec 2015 New trial record